|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||||||
| Current assets | |||||||||||||
| Cash and cash equivalents | |||||||||||||
| Marketable securities | |||||||||||||
| Prepaid expenses and other current assets | |||||||||||||
| Total current assets | |||||||||||||
| Restricted cash and investments | |||||||||||||
| Property and equipment, net | |||||||||||||
| Intangible assets, net | |||||||||||||
| Goodwill | |||||||||||||
| Other assets | |||||||||||||
| Total assets | |||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY | |||||||||||||
| Current liabilities | |||||||||||||
| Accounts payable | |||||||||||||
| Contingent consideration | |||||||||||||
| Accrued expenses and other current liabilities | |||||||||||||
| Deferred revenue | |||||||||||||
| License obligations | |||||||||||||
| Options early exercise liability | |||||||||||||
| Total current liabilities | |||||||||||||
| Deferred rent | |||||||||||||
| Options early exercise noncurrent liability | |||||||||||||
| Deferred revenue, less current portion | |||||||||||||
| Contingent consideration | |||||||||||||
| Other non-current liabilities | |||||||||||||
| Total liabilities | |||||||||||||
| STOCKHOLDERS' EQUITY | |||||||||||||
| Preferred Stock, $0.001 par value, 10,000,000 shares authorized, 0 shares issued and outstanding at June 30, 2017 and December 31, 2016 | |||||||||||||
| Common stock, $0.001 par value, 200,000,000 shares authorized, 57,078,307 and 50,083,355 shares issued and outstanding, excluding 0 and 298,758 shares subject to repurchase at June 30, 2017 and December 31, 2016, respectively | |||||||||||||
| Additional paid-in capital | |||||||||||||
| Accumulated other comprehensive loss | |||||||||||||
| Accumulated deficit | |||||||||||||
| Series A Preferred Stock | |||||||||||||
| Total stockholders' equity | |||||||||||||
| Total liabilities and stockholders' equity | |||||||||||||
Loading...
